Co-amoxiclav

Phase 3Small molecule

IImperial College London

Co-amoxiclav is one of 10 small molecule programs targeting Complication. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

AntibioticTerminated

AntibioticPhase 3

Terminated

Competition

Competitive Landscape

10 competitors in Antibiotic

#DrugCompanyPhaseTrials

Acanya

Pfizer

Approved

1 2

Amoxil

GGlobal Antibiotics Research and Development Partnership

Approved

4 3

Levaquin

WWim Janssens

Approved

3 4

Rocephin

CConrado Roberto Hoffmann Filho

Phase 3

3 5

Cefzil

CCordenpharma

Approved

1 6

Amoxicillin-Clavulanate

IIterum Therapeutics, International Limited

Phase 3

3 7

Co-amoxiclav

IImperial College London

Phase 3

2 8

Keflex

Eli Lilly

Preclinical

1 9

Ancef

BBaxter Healthcare Corporation

Preclinical

3 10

Ceftin

PPhiladelphia Eye Associates

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q2 2027

PreclinicalNot yet recruiting

Antibiotic

NCT07785206

Clinical

Trials by Indication[1]

Antibiotic2 trials

Routine Antibiotic vs. Directed Antibiotic Treatment in Snake Bite

Terminated·JJawaharlal Institute of Postgraduate Medical Education & Research·Phase 4·NCT02570347·66 enrolled

Effectiveness of Saccharomyces Boulardii in the Prevention of Antibiotic-Associated Diarrhea Among Children Receiving Co-amoxiclav for Upper Respiratory Tract Infection: A Randomized Control Trial

Not yet recruiting·UUniversity of Child Health Sciences and Children's Hospital, Lahore·Preclinical·NCT07785206·88 enrolled

Wound Infection2 trials

Does Antibiotics Use During Surgery Help to Decrease Wound Infection and Increase Success After Ear Surgery in Children

Completed·TTribhuvan University, Nepal·Phase 4·NCT03700814·60 enrolled

Prophylaxis Of Wound Infections- Antibiotics in Renal Donation

Completed·GGuy's and St Thomas' NHS Foundation Trust·Phase 4·NCT02089568·284 enrolled

Complication1 trial

Preoperative Dose of Co-amoxiclav for Prevention of Postoperative Complications in Dentoalveolar Surgery

Unknown status·TTaibah University·N/A·NCT03844776·135 enrolled

Inflammation1 trial

Preschool Wheeze: Inflammation/Infection Guided Management

Completed·IImperial College London·Phase 2·NCT02517099·60 enrolled

Antibiotic Prophylaxis1 trial

Antibiotic Prophylaxis for PEG in Children

Unknown status·AAzienda Policlinico Umberto I·Phase 4·NCT01870167·90 enrolled

2 more indications

Amputation1 trial

The Amputation Surgical Site Infection Trial (ASSIT)

Completed·HHull University Teaching Hospitals NHS Trust·Phase 4·NCT02018094·160 enrolled

Pneumonia, Community-Acquired1 trial

Efficacy and Safety of Faropenem in Bangladeshi Adult Patients With Community-Acquired Bacterial Pneumonia (CABP): A Randomized Controlled Trial

Completed·DDr. Md. Alimur Reza·Approved·NCT06804096·129 enrolled

Sources

References

[1]
ClinicalTrials.gov — 9 trial records for Co-amoxiclav. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Co-amoxiclav compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Co-amoxiclav. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Imperial College London company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: IImperial College London

Co-amoxiclav

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q2 2027

Trials by Indication[1]

Antibiotic2 trials

Wound Infection2 trials

Complication1 trial

Inflammation1 trial

Antibiotic Prophylaxis1 trial

Amputation1 trial

Pneumonia, Community-Acquired1 trial

References

Drug Info

Quick Facts

Related News